← Back to Search

Retinal Prosthesis

New VPU with bipolar stimulation for Retinitis Pigmentosa

N/A
Recruiting
Led By James Weiland
Research Sponsored by University of Michigan
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 8 hours
Awards & highlights

Study Summary

This trial will test new ways to stimulate and train the retina in order to improve the vision of those with retinal prosthesis.

Eligible Conditions
  • Retinitis Pigmentosa

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 8 hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 8 hours for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in shape perception
Percent change in stimulus thresholds

Trial Design

1Treatment groups
Experimental Treatment
Group I: Retinal stimulationExperimental Treatment2 Interventions
Alternative stimulus patterns will be tested (vs. baseline). The intervention is the alternative stimulus pattern. The intervention will be tested only in the clinic vs. baseline. The subject will go home with baseline settings. The two alternative stimulus patterns to be tested are asymmetric waveforms and bipolar stimulus.

Find a Location

Who is running the clinical trial?

National Eye Institute (NEI)NIH
546 Previous Clinical Trials
1,401,908 Total Patients Enrolled
23 Trials studying Retinitis Pigmentosa
14,351 Patients Enrolled for Retinitis Pigmentosa
University of MichiganLead Sponsor
1,796 Previous Clinical Trials
6,377,933 Total Patients Enrolled
3 Trials studying Retinitis Pigmentosa
520 Patients Enrolled for Retinitis Pigmentosa
James WeilandPrincipal Investigator - University of Michigan
University of Michigan

Media Library

New visual processing unit (VPU) with asymmetric waveforms (Retinal Prosthesis) Clinical Trial Eligibility Overview. Trial Name: NCT03635645 — N/A
Retinitis Pigmentosa Research Study Groups: Retinal stimulation
Retinitis Pigmentosa Clinical Trial 2023: New visual processing unit (VPU) with asymmetric waveforms Highlights & Side Effects. Trial Name: NCT03635645 — N/A
New visual processing unit (VPU) with asymmetric waveforms (Retinal Prosthesis) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03635645 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who else is applying?

What state do they live in?
Texas
How old are they?
18 - 65
What portion of applicants met pre-screening criteria?
Met criteria
~3 spots leftby Apr 2025